Skip to main navigation

home

Home

about

our company

Our Science

our pipeline

Pipeline

our science

Contact

our clinical trials

IR Nav

investors & media

Quarterly Results

Quarterly Results

Show all

2022

Q2

Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations

Q1

Aprea Therapeutics Announces Acquisition of Atrin Pharmaceuticals Inc. and Reports First Quarter 2022 Financial Results

2021

Q4

Aprea Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Update on Business Operations

Q3

Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on Business Operations

Q2

Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on Business Operations

Q1

Aprea Therapeutics Reports First Quarter 2021 Financial Results and Provides Update on Business Operations

2020

Q4

Aprea Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Update on Business Operations

Q3

Aprea Therapeutics Reports Third Quarter 2020 Financial Results and Provides Update on Business Operations

Q2

Aprea Therapeutics Reports Second Quarter 2020 Financial Results and Provides Update on Business Operations

Q1

Aprea Therapeutics Reports First Quarter 2020 Financial Results and Provides Update on Business Operations

2019

Q4

Aprea Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

Q3

Aprea Therapeutics Reports Third Quarter 2019 Financial Results

sub Financial

Financials

SEC Filings
Quarterly Results
Annual Reports

Shareholder Tools

USA

535 Boylston St.
Boston, MA 02116

USA

3805 Old Easton Road
Doylestown, PA 18902

CONTACT

© 2022 Aprea Therapeutics.

home

Home

about

our company

Our Science

our pipeline

Pipeline

our science

Contact

our clinical trials

IR Nav

investors & media